Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target

Clinical Cancer Research

Volumn 9, Issue 8, 2003, Pages 2926-2932

  Komdeur, Rudy ^a   Hoekstra, Harald J ^a   Molenaar, Willemina M ^a   Van den Berg, Eva ^a   Zwart, Nynke ^a   Pras, Elisabeth ^a   Plaza Menacho, Iwan ^a   Hofstra, Robert M W ^a   Van der Graaf, Winette T A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE; STEM CELL FACTOR;

ADOLESCENT; ADULT; AGED; ANGIOSARCOMA; ARTICLE; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; PATHOLOGY; POSTRADIATION SARCOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION SICKNESS; SARCOMA;

ADOLESCENT; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; EXONS; FEMALE; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, RADIATION-INDUCED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; RADIOTHERAPY; SARCOMA; SOFT TISSUE NEOPLASMS; TIME FACTORS;

EID: 0043026902     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kuten, A., Sapir, D., Cohen, Y., Haim, N., Borovik, R., and Robinson, E. Postirradiation soft tissue sarcoma occurring in breast cancer patients: report of seven cases and results of combination chemotherapy. J. Surg. Oncol., 28: 168-171, 1985.
2. Miettinen, M., Sarlomo-Rikala, M., and Lasota, J. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod. Pathol., 13: 536-541, 2000.
3. Besmer, P., Murphy, J. E., George, P. C., Qiu, F. H., Bergold, P. J., Lederman, L., Snyder, H. W., Jr., Brodeur, D., Zuckerman, E. E., and Hardy, W. D. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (Lond.), 320: 415-421, 1986.
4. Sarlomo-Rikala, M., Kovatich, A. J., Barusevicius, A., and Miettinen, M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod. Pathol., 11: 728-734, 1998.
5. Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., Muhammad, T. G., Matsuzawa, Y., Kanakura, Y., Shinomura, Y., and Kitamura, Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science (Wash. DC), 279: 577-580, 1998.
6. Taniguchi, M., Nishida, T., Hirota, S., Isozaki, K., Ito, T., Nomura, T., Matsuda, H., and Kitamura, Y. Effect of c-kit on prognosis of gastrointestinal stromal tumors. Cancer Res., 59: 4297-4300, 1999.
7. Rubin, B. P., Singer, S., Tsao, C., Duensing, A., Lux, M. L., Ruiz, R., Hibbard, M. K., Chen, C. J., Xiao, S., Tuveson, D. A., Demetri, G. D., Fletcher, C. D., and Fletcher, J. A. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res., 61: 8118-8121, 2001.
8. Plaat, B. E., Hollema, H., Molenaar, W. M., Torn Broers, G. H., Pijpe, J., Mastik, M. F., Hoekstra, H. J., van den Berg, E., Scheper, R. J., and van der Graaf, W. T. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J. Clin. Oncol., 18: 3211-3220, 2000.
9. Tuveson, D. A., Willis, N. A., Jacks, T., Griffin, J. D., Singer, S., Fletcher, C. D., Fletcher, J. A., and Demetri, G. D. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene, 20: 5054-5058, 2001.
10. Blanke, C. D., von Mehren, M., Joensuu, H., Roberts, P. J., Eisenberg, B., Heinrich, M. C., Druker, B. J., Tuveson, D., Dimitrijevic, S., Silberman, S., and Demetri, G. D. Evaluation of the safety and efficacy of an oral molecularly-targeted therapy, STI571, in patients (pts) with unresectable or metastatic gastrointestinal stromal tumors (GISTs) expressing c-kit (CD117). Proc. Am. Soc. Clin. Oncol. Annu. Meet., 20, 2001.
11. van Oosterom, A. T., Judson, I., Verweij, J., Stroobants, S., Donato, d. P., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., van Glabbeke, M., Silberman, S., and Nielsen, O. S. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal turnouts: a phase I study. Lancet, 358: 1421-1423, 2001.
12. Heinrich, M. C., Corless, C. L., Blanke, C. D., Demetri, G. D., Joensuu, H., von Mehren, M., McGreevey, L. S., Wait, C. L., Griffith, D. J., Chen, C. J., Haley, A., Kiese, B., Druker, B., Roberts, P. J., Eisenberg, B., Singer, S., Silberman, S., Dimitrijevic, S., Fletcher, C. D., and Fletcher, J. A. KIT mutational status predicts clinical response to STI571 in patients with metastatic gastrointestinal stromal tumors (GISTs). Proc. Am. Soc. Clin. Oncol. Annu. Meet., 21, 2002.
13. Arlen, M., Higinbotham, N. L., Huvos, A. G., Marcove, R. C., Miller, T., and Shah, I. C. Radiation-induced sarcoma of bone. Cancer (Phila.), 28: 1087-1099, 1971.
14. Lagrange, J. L., Ramaioli, A., Chateau, M. C., Marchal, C., Resbeut, M., Richaud, P., Lagarde, P., Rambert, P., Tortechaux, J., Seng, S. H., de la Fontan, B., Reme-Saumon, M., Bof, J., Ghnassia, J. P., and Coindre, J. M. Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically-confirmed cases. Radiology, 216: 197-205, 2000.
15. Weiss, S. W., and Goldblum, J. R. Enzinger and Weiss's Soft Tissue Tumors. 4th Ed., pp. 7-8. St. Louis: Mosby, 2001.
16. Allander, S. V., Nupponen, N. N., Ringner, M., Hostetter, G., Maher, G. W., Goldberger, N., Chen, Y., Carpten, J., Elkahloun, A. G., and Meltzer, P. S. Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile. Cancer Res., 61: 8624-8628, 2001.
17. Lux, M. L., Rubin, B. P., Biase, T. L., Chen, C. J., Maclure, T., Demetri, G., Xiao, S., Singer, S., Fletcher, C. D., and Fletcher, J. A. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am. J. Pathol., 156: 791-795, 2000.
18. Miettinen, M. Are desmoid tumors kit positive? Am. J. Surg. Pathol., 25: 549-550, 2001.
19. Torihashi, S., Horisawa, M., and Watanabe, Y. c-Kit immunoreactive interstitial cells in the human gastrointestinal tract. J. Auton. Nerv. Syst., 75: 38-50, 1999.
20. Mullenbach, R., Lagoda, P. J., and Welter, C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet., 5: 391, 1989.
21. Mertens, F., Larramendy, M., Gustavsson, A., Gisselsson, D., Rydholm, A., Brosjo, O., Mitelman, F., Knuutila, S., and Mandahl, N. Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p. Cancer Genet. Cytogenet., 116: 89-96, 2000.
22. Laskin, W. B., Silverman, T. A., and Enzinger, F. M. Postradiation soft tissue sarcomas. An analysis of 53 cases. Cancer (Phila.), 62: 2330-2340, 1988.
23. Amendola, B. E., Amendola, M. A., McClatchey, K. D., and Miller, C. H., Jr. Radiation-associated sarcoma: a review of 23 patients with postradiation sarcoma over a 50-year period. Am. J. Clin. Oncol., 12: 411-415, 1989.
24. Polgar, C., Orosz, Z., and Fodor, J. Is postirradiation angiosarcoma of the breast so rare and does breast lymphedema contribute to its development? J. Surg. Oncol., 76: 239-241, 2001.
25. Hasegawa, T., Matsuno, Y., Niki, T., Hirohashi, S., Shimoda, T., Takayama, J., Watanabe, C., Kaneko, A., Sano, T., Sato, M., and Suzuki, J. Second primary rhabdomyosarcomas in patients with bilateral retinoblastoma: a clinicopathologic and immunohistochemical study. Am. J. Surg. Pathol., 22: 1351-1360, 1998.
26. Wiklund, T. A., Blomqvist, C. P., Raty, J., Elomaa, I., Rissanen, P., and Miettinen, M. Postirradiation sarcoma. Analysis of a nationwide cancer registry material. Cancer (Phila.), 68: 524-531, 1991.
27. Inoue, Y. Z., Frassica, F. J., Sim, F. H., Unni, K. K., Petersen, I. A., and McLeod, R. A. Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue. J. Surg. Oncol., 75: 42-50, 2000.
28. Cafiero, F., Gipponi, M., Peressini, A., Queirolo, P., Bertoglio, S., Comandini, D., Percivale, P., Sertoli, M. R., and Badellino, F. Radiation-associated angiosarcoma: diagnostic and therapeutic implications-two case reports and a review of the literature. Cancer (Phila.), 77: 2496-2502, 1996.
29. Souba, W. W., McKenna, R. J., Jr., Meis, J., Benjamin, R., Raymond, A. K., and Mountain, C. F. Radiation-induced sarcomas of the chest wall. Cancer (Phila.), 57: 610-615, 1986.
30. Bielack, S. S., Kempf-Bielack, B., Heise, U., Schwenzer, D., and Winkler, K. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. J. Clin. Oncol., 17: 1164, 1999.
31. Cefalo, G., Ferrari, A., Tesoro-Tess, J. D., Gianni, M. C., Fossati-Bellani, F., Lombardi, F., and Massimino, M. Treatment of childhood post-irradiation sarcoma of bone in cancer survivors. Med. Pediatr. Oncol., 29: 568-572. 1997.
32. Tabone, M. D., Terrier, P., Pacquement, H., Brunat-Mentigny, M., Schmitt, C., Babin-Boilletot, A., Mahmoud, H. H., and Kalifa, C. Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases. J. Clin. Oncol., 17: 2789-2795, 1999.
33. Hornick, J. L., and Fletcher, C. D. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am. J. Clin. Pathol., 117: 188-193, 2002.
34. Bellone, G., Carbone, A., Sibona, N., Bosco, O., Tibaudi, D., Smirne, C., Martone, T., Gramigni, C., Camandona, M., Emanuelli, G., and Rodeck, U. Aberrant activation of c-kit, protects colon carcinoma cells against apoptosis and enhances their invasive potential. Cancer Res., 61: 2200-2206, 2001.